Starmer’s Beijing Trip Marks a Quiet Shift in Britain’s China Policy
Britain's first prime ministerial visit to China in eight years yields $15 billion pharmaceutical investment, signaling strategic shift toward pragmatic engagement in life sciences and emerging technologies.